Mustang Bio (MBIO) EBT Margin (2018)
Mustang Bio (MBIO) posted quarterly EBT Margin of 12662.0% for Q1 2018.
Mustang Bio (MBIO) EBT Margin (2018) Analysis & Trends
Mustang Bio (MBIO) has reported EBT Margin for 1 consecutive years, with 12662.0% the latest figure, recorded in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 12.09% |
| 10 | Mustang Bio | 3.87 Mn | 3.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -12,662.00% |